key: cord-0300585-k7n2a7xj
authors: Lefton, Micah; Sharma, Nihaarika; Patel, Akash R.; Sparks, Jeffrey A.; Ermann, Joerg
title: Polyfunctional IL-17A+ MAIT cells are expanded in the peripheral blood of patients with HLA-B27+ axial spondyloarthritis
date: 2022-01-18
journal: bioRxiv
DOI: 10.1101/2022.01.17.475829
sha: 67522756728a9723e21838d8860cc2960ad76e1f
doc_id: 300585
cord_uid: k7n2a7xj

Objectives Studies in axial spondyloarthritis (axSpA) have yielded conflicting results regarding the identity of the major IL-17A-producing lymphocyte populations. The goal of this study was to comprehensively assess the production of IL-17A and related cytokines by peripheral blood lymphocytes in axSpA. Methods Peripheral blood mononuclear cells were isolated from patients with axSpA and healthy controls matched for age, sex and HLA-B27 status. Unstimulated cells and cells activated with PMA/Ionomycin were analyzed by 25-parameter fluorescent flow cytometry. Data were analyzed by hierarchical gating, UMAP and SPICE. Results Except for a reduced frequency of mucosal-associated invariant T (MAIT) cells and natural killer (NK) cells, there were no other significant differences in abundance of major lymphocyte populations in axSpA patients compared with controls. Increased IL-17A production in axSpA was observed in total non-B lymphocytes and in MAIT cells. The fraction of MAIT cells expressing the tissue residency markers CD69 and CD103 was increased in axSpA. CD103 positive MAIT cells were enriched for IL-17A producers. axSpA patients demonstrated an expansion of MAIT cell subsets producing IL-17A, IL-17F, GM-CSF and TNF. This expansion was only observed in HLA-B27+ patients. Conclusions We document an expansion of polyfunctional IL-17A+ MAIT cells in the peripheral blood of HLA-B27+ patients with axSpA. These results are consistent with the implied role of intestinal dysbiosis or inflammation in axSpA pathogenesis. Key messages What is already known about this subject? Various IL-17A-producing lymphocyte populations have been implicated in the pathogenesis of axSpA. What does this study add? Polyfunctional MAIT cells capable of producing IL-17A, IL-17F, GM-CSF and TNF are expanded in the peripheral blood of HLA-B27+ patients with axSpA. How might this impact on clinical practice or future developments? Overproduction of IL-17A by MAIT cells is the most consistent finding of peripheral blood lymphocyte studies in axSpA. Our data support the pathogenetic link between intestinal and axial inflammation in axSpA.

Axial spondyloarthritis (axSpA) including its more severe variant ankylosing spondylitis (AS) is an immune-mediated disease predominantly of the axial skeleton. [1] Multiple lines of evidence point toward a central role for lymphocytes in the pathogenesis of the disease. This includes the strong association with the MHC class I allele HLA-B27 as well as weaker associations, mostly identified in genome-wide association studies, with genes that encode transcription factors, cytokines and signaling modules involved in lymphocyte development, differentiation and function. [2] Antibody-mediated inhibition of the lymphocyte-derived cytokine IL-17A is now an established therapy for axSpA. [3, 4] Studies in AS and axSpA have yielded conflicting results regarding the identity of the IL-17A-producing cells. [5, 6] Given the difficulties in obtaining tissue for analysis in axSpA, these studies have been almost exclusively performed in peripheral blood. Early studies focused on CD4+ T cells and described an expansion of IL-17A-producing Th17 cells. [7, 8] . More recently, increased IL-17A production in axSpA was reported for a variety of innate-like lymphocytes including γ δ T cells [9] , invariant natural killer T (iNKT) cells [10] and mucosal-associated invariant T (MAIT) cells. [11] [12] [13] A comprehensive analysis of these cell types in the same study has not been performed. It is therefore not clear whether there is a general dysregulation of IL-17A production in axSpA or whether subsets of patients can be distinguished with selective expansion of distinct IL-17A+ lymphocyte populations.

To address this question, we developed a high-dimensional flow cytometry panel for the comprehensive analysis of cell surface markers and intracellular cytokines. A cohort of patients with axSpA was compared to healthy controls matched for age, sex and HLA-B27 status.

Consistent with previous reports, we found a reduction of total MAIT cells in axSpA peripheral blood associated with a higher frequency of IL-17A positive cells, many of which produced additional cytokines such IL-17F, GM-CSF and TNF. The expansion of these polyfunctional MAIT cells was only seen in HLA-B27+ patients.

Patients with axial spondyloarthritis (axSpA) were recruited in the Arthritis Center at Brigham and Women's Hospital (BWH), Boston, MA. The HLA-B27 status of the axSpA patients was retrieved from medical records. Healthy controls were recruited from the Mass General Brigham (MGB) Biobank, a research repository at BWH, Massachusetts General Hospital and affiliated sites in the Greater Boston, MA, area. [14, 15] Participants in MGB Biobank provide blood to be stored for research purposes, allow for access to their electronic health record and agree to be recontacted for other research studies. About one-third of participants were randomly selected to be genotyped using ILUMINA arrays. We identified HLA-B27+/-individuals using SNP2HLA [16] and applied a filter to screen out subjects with SpA-related diseases and other inflammatory conditions or chronic conditions that might affect immune status. We then invited a random sample of 500 HLA-B27+/-healthy controls less than 55 years of age to provide a peripheral blood sample specifically for this study enrolling a total of 32 subjects that were verified to be healthy on medical record review. Prior to the flow cytometry experiment, we matched available axSpA and healthy control specimens for age, sex and HLA-B27 status selecting n=28 healthy controls and n=28 axSpA samples for inclusion in the study (Suppl. Figure S1A ). All subjects gave informed consent. The study was approved by the MGB IRB. Patients and the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

Peripheral blood was obtained by venous blood draw. Peripheral blood mononuclear cells (PBMC) were isolated using Ficoll-Paque PLUS (GE Healthcare) and cryopreserved in freezing medium containing fetal bovine serum (FBS) (Gemini) and 10% dimethyl sulfoxide (DMSO) (Sigma Aldrich).

Thawed PBMCs were seeded in 96-well round bottom plates at 2 x 10 6 cells/well in Iscove's Modified Dulbecco's Medium (Gibco) supplemented with 10% fetal bovine serum (Sigma Aldrich), sodium pyruvate (Cellgro), penicillin and streptomycin (Sigma Aldrich), nonessential amino acids (Cellgro) and 2-mercaptoethanol (Gibco). Cells were stimulated with 50 ng/mL PMA plus 100 ng/mL Ionomycin (Cell Stimulation Cocktail, Thermo Fisher Scientific), in the presence of monensin (2 ug/ml, GolgiStop, BD Bioscience) and brefeldin A (1 ug/ml, GolgiPlug, BD Bioscience) for 6 hours.

Unstimulated PBMCs were stained using the antibodies in Suppl. Table 1 . Stimulated cells were first stained for surface markers. After fixation in IC Fixation Buffer (Thermo Fisher Scientific), intracellular staining for cytokines was performed in Permeabilization Buffer (Thermo Fisher Scientific). Suppl. Table 2 lists the antibodies used for staining stimulated PBMCs. Cells were analyzed on a FACSymphony flow cytometer (BD Bioscience) and data were analyzed using FlowJo v10.8.0 (BD Bioscience). Multi-cytokine analysis was performed using SPICE v6. [17] See Suppl. Figure S1B for workflow and Suppl. methods for additional detail.

Statistical analysis and graphing were done using Prism v9.0.2 (Graphpad Software) and R v4.1.0. [18] Student t test or ANOVA were used for the analysis of parametric data. Mann Whitney U test or Kruskal-Wallis test were used for non-parametric data. A p-value <0.05 was considered statistically significant.

To characterize lymphocyte populations in axSpA, we developed two 25-parameter fluorescent flow cytometry panels (Suppl. Table 1 and 2). We applied these panels to a collection of PBMC specimens from patients with axSpA and healthy controls matched for age, sex and HLA-B27 status ( Table 1 , Suppl. Figure 1A ). 

We used hierarchical gating (Suppl. Figure 2 ) to identify CD4+ T cells, CD8+ T cells, DN reports by others, we found that the frequency of MAIT cells (identified here as CD3+αβTCR+MR-1 5-OP-RU tetramer+ cells) was significantly reduced in axSpA patients. [11] [12] [13] The frequency of NK cells (CD3-CD56+) was also lower in axSpA than in healthy controls.

There were no differences in the frequency of γ δ T cells or any of the other major lymphocyte populations. We also did not find differences between axSpA patients and healthy controls (Suppl. positive cells than healthy controls, while there was no difference in CD4+ T cells ( Figure 2D ).

IL-17F expression was largely limited to cells that expressed IL-17A. The frequency of IL-17A/IL-17F double positive cells was higher in MAIT cells from axSpA patient compared to controls, there was a non-significant trend in CD4+ T cells from axSpA patients ( Figure 2E ). We did not find differences in expression of IL-22, GM-CSF, IFNγ or TNF when analyzed individually in any of the nine major lymphocyte populations (Suppl. Figure 4) .

Considering the significant differences in expression of IL-17A and IL-17F in MAIT cells (but not other cell types) from axSpA patients and healthy controls, we focused subsequent analyses on this cell population. As expected for peripheral blood MAIT cells in adults, the MAIT cells in axSpA patients and controls were CD161+, CD127+ (IL-7R+) and largely CD8+, CD45RA-and CCR7-(Suppl. Figure 5 ). [20, 21] MAIT cells at mucosal sites strongly express the tissue residency markers CD69 and CD103. [22, 23] These markers are also expressed on some circulating MAIT cells. [24] Comparing MAIT cells from axSpA patients and healthy controls, we found an increased fraction of CD69-CD103+ cells in the patients, CD69+CD103-and CD69+CD103+ fractions also trended higher in this group ( Figure 3A ). IL-17A production upon PMA/Ionomycin stimulation was enriched in CD69-CD103+ cells, both in axSpA patients and healthy controls ( Figure 3B ).

Next, we explored the co-production of cytokines by MAIT cell subsets using a dimension reduction approach. Cytokine expression data for individual MAIT cells from axSpA patients and controls were concatenated and analyzed by UMAP, an algorithm that collapses high-dimensional data into a two-dimensional plot by clustering cells based on similarity of marker expression. Visual inspection of the UMAP plots for axSpA patients and healthy controls identified a small population of cells that was more abundant in patients ( Figure 4A ). This cluster 

Lastly, we analyzed whether the expansion of IL-17A+ MAIT cells in axSpA was associated with clinical factors. We observed a non-significant trend toward correlation with CRP but not BASDAI (Suppl. Figure 6A ). There was no difference between axSpA patients stratified based on sex or current use of biologic drugs (Suppl. Figure 6B ). However, we observed a strong correlation between the frequency of IL-17A+ MAIT cells and HLA-B27 status in axSpA patients, which was not seen in healthy controls ( Figure 5B ). Polyfunctional IL-17A+ MAIT cell populations were also increased in HLA-B27+ but not in HLA-B27-axSpA patients ( Figure 5C ).

This study compared peripheral blood lymphocytes in patients with axSpA and healthy controls We have adopted the term polyfunctional from the work by others [35] [36] [37] acknowledging that this may be a suboptimal term as the production of cytokines is arguably a single function. MAIT cells have been shown to express several lineage transcription factors providing them with the capacity to produce multiple cytokines without following the Th1/Th2/Th17 paradigm. [38] Indeed, the pie graphs in Figure 4 demonstrate that MAIT cells in both axSpA patients and healthy controls contain a substantial fraction of cells producing IFNγ, TNF and GM-CSF upon stimulation with PMA/ionomycin. However, the frequency of these polyfunctional MAIT cells was not different between patients and controls. The polyfunctional MAIT cells we found to be expanded in axSpA have IL-17A as the signature cytokine along with variable expression of IL-17F, GM-CSF and TNF. It will be interesting to further explore the heterogeneity of MAIT cells in axSpA under a variety of stimulatory conditions and measuring a higher number of parameters per cell, for instance using single-cell RNA-seq. [21, 39, 40] Our study has several strengths. Patients and healthy controls were well matched for age, sex and HLA-B27 status. This was achieved by recruiting HLA-B27 genotyped healthy controls through MGB Biobank. The flow cytometry panels permitted the simultaneous analysis of multiple lymphocyte subsets, which had previously only been analyzed in isolation. We further measured 6 cytokines per cell and used MR-1 5-OP-RU tetramers to identify MAIT cells.

Limitations include the relatively low disease activity in our axSpA cohort. While the number of subjects included in the analysis was comparable to other studies in this field, more than 60% of axSpA patients were on a biologic and their mean BASDAI score was 2.9, which is relatively low. Inclusion of more biologic-naive patients with active disease would have been desirable but recruitment was difficult given the high frequency of biologic therapy in established axSpA patients in the US. [41, 42] COVID-19 related research restrictions that went into effect in early 2020 added to this problem. Our flow cytometry panels were also not designed to specifically interrogate MAIT cells. In hindsight, inclusion of additional parameters to characterize MAIT cells (e.g. granzymes, CD107, homing receptors) would have been informative. [43] In conclusion, we demonstrate an expansion of polyfunctional IL-17A+ MAIT cells in the peripheral blood of HLA-B27+ axSpA patients. MAIT cell abnormalities, in particular an increased frequency of IL-17+ MAIT cells, have been the most consistent finding of peripheral blood lymphocyte studies in axSpA to date, suggesting that MAIT cells are a major candidate link between inflammation in the gut and inflammation in the axial skeleton. 

Ankylosing Spondylitis and Axial Spondyloarthritis

Genetics in ankylosing spondylitis -Current state of the art and translation into clinical outcomes

2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis

Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis. Arthritis Rheumatol

Pathogenesis of Axial Spondyloarthritis -Sources and Current State of Knowledge

Cellular and molecular diversity in spondyloarthritis

Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis

Sexual Dimorphism in the Th17 Signature of Ankylosing Spondylitis

Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive gamma/delta T cells in patients with active ankylosing spondylitis

RORgammat inhibition selectively targets IL-17 producing iNKT and gammadelta-T cells enriched in Spondyloarthritis patients

IL-7 primes IL-17 in mucosal-associated invariant T (MAIT) cells, which contribute to the Th17-axis in ankylosing spondylitis

Involvement of Mucosal-associated Invariant T cells in Ankylosing Spondylitis

Increased IL-22-and IL-17A-Producing Mucosal-Associated Invariant T Cells in the Peripheral Blood of Patients With Ankylosing Spondylitis

Implementation of Electronic Consent at a Biobank: An Opportunity for Precision Medicine Research

Building the Partners HealthCare Biobank at Partners Personalized Medicine: Informed Consent, Return of Research Results, Recruitment Lessons and Operational Considerations

Imputing amino acid polymorphisms in human leukocyte antigens

SPICE: exploration and analysis of post-cytometric complex multivariate datasets

R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing

Integrin and transcriptomic profiles identify a distinctive synovial CD8+ T cell subpopulation in spondyloarthritis

Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. Blood

Human Mucosal-Associated Invariant T Cells in Older Individuals Display Expanded TCRαβ Clonotypes with Potent Antimicrobial Responses

Mucosal-Associated Invariant T Cells in the Human Gastric Mucosa and Blood: Role in Helicobacter pylori Infection

Tissue-resident MAIT cell populations in human oral mucosa exhibit an activated profile and produce IL

A common transcriptomic program acquired in the thymus defines tissue residency of MAIT and NKT subsets

Characterization of Human Mucosal-associated Invariant T (MAIT) Cells

Mucosal-associated invariant T cell deficiency in systemic lupus erythematosus

TNFα and IL-1β in the synovial fluid facilitate mucosal-associated invariant T (MAIT) cell migration

MAIT cell activation and dynamics associated with COVID-19 disease severity

Mucosal-associated invariant T cells and disease

Activation status of mucosal-associated invariant T cells reflects disease activity and pathology of systemic lupus erythematosus

Human MAIT cells exit peripheral tissues and recirculate via lymph in steady state conditions

HLA Alleles Associated With Risk of Ankylosing Spondylitis and Rheumatoid Arthritis Influence the Gut Microbiome

Intestinal dysbiosis in spondyloarthritis -chicken or egg?

Revisiting the gut-joint axis: links between gut inflammation and spondyloarthritis

TCR-or Cytokine-Activated CD8(+) Mucosal-Associated Invariant T Cells Are Rapid Polyfunctional Effectors That Can Coordinate Immune Responses

Polyfunctional TEM cells in psoriatic arthritis synovium skewed towards Th17 cells

Proinflammatory, Tissue-Resident Memory Phenotype and Function of Synovial Interleukin-17A+CD8+ T Cells in Psoriatic Arthritis

MAIT Cells in Health and Disease

Human MAIT Cell Activation In Vitro

Single-Cell Transcriptomic Profiling of MAIT Cells in Patients With COVID-19

Comparison of comorbidities and treatment between ankylosing spondylitis and non-radiographic axial spondyloarthritis in the United States. Rheumatology (Oxford)

Characterization of Patients With Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis in the US-Based Corrona Registry

Type I interferons are important co-stimulatory signals during T cell receptor mediated human MAIT cell activation

We would like to thank Dr. Lianne Gensler, UCSF, for providing the DX31 antibody. Jake Lawicky, Greg Keras, H. Maura Friedlander, Alessandra Zaccardelli, Lauren Prisco and LilyMarin helped with patient recruitment.